CSI Market
Sign In | Register

Vanda Pharmaceuticals Inc (VNDA) Annual Balance Sheets

Annual · GAAP · USD millions
Access VNDA quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Vanda Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent84.85
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments84.00
Accounts receivable54.58
Inventories1.85
Other Current Assets179.00
Prepaid Expense And Other Assets Current26.99
Total Current Assets347.26
Equipment/Property/Plant Net2.25
Intangible Assets117.09
Other Assets, Noncurrent22.35
Inventory And Other Non Current11.08
Total Assets488.95
Liabilities
Accounts Payable and Accrued Liabilities, Current LI68.30
Other Liabilities, Current0.00
Total Current Liabilities145.16
Total Long-term Debt0.00
Other liabilities, Noncurrent16.60
Product Revenue Allowances Current76.87
Total Liabilities161.76
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock721.26
Retained Earnings / Accumulated Deficit-394.77
Other Equity0.63
Common Stockholder's Equity327.19
Total Stockholder's Equity327.19
Liabilities & Stockholder's Equity488.95
4 historic quarters locked

Sign in to unlock the full Vanda Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Vanda Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: vnda-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-007460

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License